Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by P. Parent.
Journal of Medical Genetics | 2005
Christel Thauvin-Robinet; M Cossée; Valérie Cormier-Daire; L. Van Maldergem; Annick Toutain; Y Alembik; Eric Bieth; Valérie Layet; P. Parent; Albert David; Alice Goldenberg; Geert Mortier; Delphine Héron; Paul Sagot; A M Bouvier; Frédéric Huet; V Cusin; Anne Donzel; D Devys; Jean-Raymond Teyssier; L. Faivre
Oral–facial–digital syndrome type 1 (OFD1) is characterised by an X linked dominant mode of inheritance with lethality in males. Clinical features include facial dysmorphism with oral, tooth, and distal abnormalities, polycystic kidney disease, and central nervous system malformations. Large interfamilial and intrafamilial clinical variability has been widely reported, and 18 distinct mutations have been previously reported within OFD1. A French and Belgian collaborative study collected 25 cases from 16 families. OFD1 was analysed using direct sequencing and phenotype–genotype correlation was performed using χ2 test. X inactivation studies were performed on blood lymphocytes. In 11 families, 11 novel mutations, including nine frameshift, one nonsense, and one missense mutation were identified, which spanned nine different exons. A combination of our results with previously reported cases showed that the majority of mutations (65.5%) was located in exons 3, 8, 9, 13, and 16. There was phenotype–genotype correlation between (a) polycystic kidney disease and splice mutations; (b) mental retardation and mutations located in exons 3, 8, 9, 13, and 16; and (c) tooth abnormalities and mutations located in coiled coil domains. Comparing the phenotype of the families with a pathogenic mutation to families with absence of OFD1 mutation, polycystic kidneys and short stature were significantly more frequent in the group with no OFD1 mutation, whereas lingual hamartomas were significantly more frequent in the group with OFD1 mutation. Finally, an X inactivation study showed non-random X inactivation in a third of the samples. Differential X inactivation between mothers and daughters in two families with high intrafamilial variability was of particular interest. Slight phenotype–genotype correlations were established, and X inactivation study showed that skewed X inactivation could be partially involved in the pathogenesis of intrafamilial clinical variability.
The Lancet | 2000
Virginie Scotet; Marc De Braekeleer; Michel Roussey; G. Rault; P. Parent; Michel Dagorne; Hubert Journel; Auguste Lemoigne; Jean-Pierre Codet; Michel Catheline; Véronique David; André Chaventré; I. Duguépéroux; Claudine Verlingue; Isabelle Quere; Bernard Mercier; Marie-Pierre Audrézet; Claude Férec
BACKGROUND Neonatal screening for cystic fibrosis has been a subject of debate over the past few years. This study assesses 10 years of neonatal screening in Brittany, France, and examines its impact on prenatal screening of subsequent pregnancies in couples with an affected child. METHODS The study included all the neonates screened for cystic fibrosis in Brittany from Jan 1, 1989, to Dec 31, 1998. The screening consisted of an immunoreactive trypsinogen assay from dried blood spots, plus, from 1993, mutation analysis. Data were collected on incidence of cystic fibrosis, and genotypic and biochemical characteristics. The use of prenatal screening of subsequent pregnancies in affected families was also investigated. FINDINGS Of the 343,756 neonates screened, 118 children with cystic fibrosis were identified, giving an incidence of one in 2913. All mutated alleles were characterised: 34 different mutations resulting in 36 genotypes were detected. The introduction of DNA analysis into the protocol greatly reduced the recall rate and increased the sensitivity of the test. The mean cost of the screening programme was US
American Journal of Medical Genetics Part A | 2005
L. Pinson; A. Perrin; C. Plouzennec; P. Parent; C. Metz; M. Collet; M.-J. Le Bris; Nathalie Douet-Guilbert; Frédéric Morel; M. De Braekeleer
2.32 per screened child. 39 (34%) of the families identified by neonatal screening opted for subsequent prenatal diagnosis at least once. 12 couples would have benefited from this procedure while their first child was still symptom-free. 42 healthy children were born, and 18 pregnancies were terminated (therapeutic abortion rate of 100%). INTERPRETATION We have shown the feasibility of neonatal screening for cystic fibrosis in Brittany. Through the detection of a large range of mutations, neonatal screening provides the opportunity for more reliable prenatal diagnosis and cascade screening. The neonatal screening programme described here could provide a good model for other countries intending to initiate such a scheme.
Clinical Genetics | 2001
Virginie Scotet; M. De Braekeleer; Marie-Pierre Audrézet; L. Lodé; Claudine Verlingue; Isabelle Quere; Bernard Mercier; I. Duguépéroux; Jean-Pierre Codet; M.-P. Moineau; P. Parent; Claude Férec
Unlike the small proximal 15q deletions causing Prader‐Willi and/or Angelman syndrome, distal deletions of the terminal long arm of chromosome 15 have rarely been described. To the best of our knowledge, only four patients with a pure terminal 15q deletion have been documented in the literature. We report here on an unexpected abnormal hybridization pattern for the 15q specific subtelomeric control probe (clone 154P1) of the commercial SNRPN probe in a girl referred for suspicion of Angelman syndrome. Investigation by fluorescent in situ hybridization (FISH) using bacterial artificial chromosome (BAC) clones defined a partial monosomy 15q26.2 → 15qter for a minimal critical region of approximately 5.7 Mb, which is the most distal de novo 15qter deletion reported to date. All the de novo 15qter deletion cases, including ours, presented with pre‐ and post‐natal growth retardation related to the loss of one copy of the IGF1R gene. Based on the comparaison with the previous published cases and owing to the clinical phenotype of our patient, we define a new subtelomeric 15qter syndrome which would be characterized by intrauterine growth retardation and global post‐natal growth failure, variable mental retardation, facial anomalies including relative micrognathia and triangular facies and minor malformations of the extremities including proximally placed thumbs, cubitus valgus, and brachydactyly with tappering of the digits.
Human Genetics | 2002
Virginie Scotet; Dominique Gillet; I. Duguépéroux; Marie-Pierre Audrézet; Gil Bellis; Bénédicte Garnier; Michel Roussey; Gilles Rault; P. Parent; Marc De Braekeleer; Claude Férec; Réseau Mucoviscidose Bretagne et Pays de Loire
Nowadays, most of the neonatal screening programs for cystic fibrosis (CF) combine the assay of immunoreactive trypsinogen (IRT) with the analysis of the most common mutations of the CFTR gene. The efficiency of this strategy is now well established, but the identification of heterozygotes among neonates with increased IRT is perceived as a drawback. We proposed to assess the heterozygosity frequency among the children with hypertrypsinaemia detected through the CF screening program implemented in Brittany (France) 10 years ago, to describe the CFTR mutations detected in them and to determine the frequency of the IVS8‐5T variant. The molecular analysis relies, in our protocol, on the systematic analysis of three exons of the gene (7‐10‐11). A total of 160 019 babies were screened for CF in western Brittany between 1992 and 1998. Of the 1 964 newborns with increased IRT (1.2%), 60 were CF and 213 were carriers. Heterozygosity frequency was 12.8%, i.e. 3 times greater than in the general population (3.9%; p<10−6). Variability of mutations detected in carriers was greater than in CF children (21 mutations versus 10) and a high proportion of mild mutations or variants (A349V, R297Q, R347H, V317A, G544S, R553G, etc) was observed in carriers. The allelic frequency of the 5T (5.6%) was not significantly increased in this cohort. This study is consistent with previous ones in finding a significantly higher rate of heterozygotes than expected among neonates with hypertrypsinaemia. The strategy of screening used here allows to highlight the variability of mutations detected in heterozygotes and to show that severe mutations, as well as mild mutations, have been observed in neonates with hypertrypsinaemia. If there is no doubt that neonatal hypertrypsinaemia is associated with an elevated frequency of carriers, the underlying mechanisms remain obscure.
American Journal of Medical Genetics Part A | 2016
Patricia Fergelot; Martine J. van Belzen; Julien Van Gils; Alexandra Afenjar; Christine M. Armour; Benoit Arveiler; Lex Beets; Lydie Burglen; Tiffany Busa; Marie Collet; Julie Deforges; Bert B.A. de Vries; Elena Dominguez Garrido; Nathalie Dorison; Juliette Dupont; Christine Francannet; Sixto García-Miñaúr; Elisabeth Gabau Vila; Samuel Gebre-Medhin; Blanca Gener Querol; David Geneviève; Marion Gerard; Cristina Gervasini; Alice Goldenberg; Dragana Josifova; Katherine Lachlan; Saskia M. Maas; Bruno Maranda; Jukka L. Moilanen; Ann Nordgren
Abstract. Cystic fibrosis (CF) is the most common severe inherited disorder that affects children in Caucasian populations. The aim of this study was to define the spatial and temporal distribution of CF and its mutations in Brittany (western France) where the frequency of the disease is high. We retrospectively registered all CF patients born in Brittany since 1960 by cross-checking various data sources (e.g. medical care centres, genetics laboratories, hospital archives). Councils were contacted so that the place of residence of patients at birth could be determined. Moreover, the spectrum of CF transmembrane conductance regulator (CFTR) mutations and their spatial distribution across Brittany were determined. A total of 520 patients was registered in this study. The incidence of CF was assessed according to administrative (department, district) and diocesan divisions of Brittany and its evolution analysed over four decades. The incidence of CF was 1/2630, with a west/east gradient that was confirmed over time (Finistère: 1/2071 vs Ille-et-Vilaine: 1/3286). At present, the incidence of CF is decreasing, mainly as a result of prenatal diagnosis. An excellent mutation detection rate of 99.7% was obtained. Western Brittany presented a specific spectrum of mutations: 1078delT (9.4% of mutated alleles in the diocese of Cornouaille), G551D (7.7% in the diocese of Léon), 4005+1G→A (2.9% in Cornouaille) and W846X (1.5% in western Brittany). On the other hand, the eastern region showed a spectrum more similar to the overall picture in France as a whole. This study enabled a precise measurement of the incidence of CF in Brittany to be obtained. The high frequency of the CFTR mutated alleles may result from founder effects and genetic drifts. Moreover, the study brings together the regional specificities of the CFTR gene and highlights disparities that exist in this part of France, both in incidence and in mutation distribution. These are attributable to different degrees of isolation and of population movements between the eastern and western parts of the region. Given that this is the first time that such a detailed study of the CFTR gene has been performed on a large population, this heightened knowledge of the epidemiology of CF in Brittany should provide a basis for the improvement of diagnostic strategies and refinement of genetic counselling.
American Journal of Medical Genetics Part A | 2007
H. Marical; M.-J. Le Bris; Nathalie Douet-Guilbert; P. Parent; J.P. Descourt; Frédéric Morel; M. De Braekeleer
Rubinstein–Taybi syndrome (RSTS) is a developmental disorder characterized by a typical face and distal limbs abnormalities, intellectual disability, and a vast number of other features. Two genes are known to cause RSTS, CREBBP in 60% and EP300 in 8–10% of clinically diagnosed cases. Both paralogs act in chromatin remodeling and encode for transcriptional co‐activators interacting with >400 proteins. Up to now 26 individuals with an EP300 mutation have been published. Here, we describe the phenotype and genotype of 42 unpublished RSTS patients carrying EP300 mutations and intragenic deletions and offer an update on another 10 patients. We compare the data to 308 individuals with CREBBP mutations. We demonstrate that EP300 mutations cause a phenotype that typically resembles the classical RSTS phenotype due to CREBBP mutations to a great extent, although most facial signs are less marked with the exception of a low‐hanging columella. The limb anomalies are more similar to those in CREBBP mutated individuals except for angulation of thumbs and halluces which is very uncommon in EP300 mutated individuals. The intellectual disability is variable but typically less marked whereas the microcephaly is more common. All types of mutations occur but truncating mutations and small rearrangements are most common (86%). Missense mutations in the HAT domain are associated with a classical RSTS phenotype but otherwise no genotype–phenotype correlation is detected. Pre‐eclampsia occurs in 12/52 mothers of EP300 mutated individuals versus in 2/59 mothers of CREBBP mutated individuals, making pregnancy with an EP300 mutated fetus the strongest known predictor for pre‐eclampsia.
Human Mutation | 2016
Bertrand Isidor; Sébastien Küry; Jill A. Rosenfeld; Thomas Besnard; Sébastien Schmitt; Shelagh Joss; Sally Davies; Robert Roger Lebel; Alex Henderson; Christian P. Schaaf; Haley Streff; Yaping Yang; Vani Jain; Nodoka Chida; Xénia Latypova; Cédric Le Caignec; Benjamin Cogné; Sandra Mercier; Marie Vincent; Estelle Colin; Dominique Bonneau; Anne-Sophie Denommé; P. Parent; Brigitte Gilbert-Dussardier; Sylvie Odent; Annick Toutain; Amélie Piton; Christian Dina; Audrey Donnart; Pierre Lindenbaum
H. Marical, M.J. Le Bris, N. Douet-Guilbert, P. Parent, J.P. Descourt, F. Morel, and M. De Braekeleer* Service de Cytogénétique, Cytologie et Biologie de la Reproduction, CHU Morvan, Brest, France Laboratoire d’Histologie, Embryologie et Cytogénétique, Faculté de Médecine et des Sciences de la Santé, Université de Bretagne Occidentale, Brest, France Service de Pédiatrie et Génétique Médicale, CHU Morvan, Brest, France Service de Pédiatrie, Clinique Kéraudren, Brest, France
Fetal Diagnosis and Therapy | 2004
G. Boog; Claudine Le Vaillant; M. Collet; Pierre Dupre; P. Parent; A. Bongain; Bernard Benoit; Claire Trastour
A rare syndromic form of intellectual disability with impaired speech was recently found associated with mutations in CHAMP1 (chromosome alignment‐maintaining phosphoprotein 1), the protein product of which is directly involved in microtubule‐kinetochore attachment. Through whole‐exome sequencing in six unrelated nonconsanguineous families having a sporadic case of intellectual disability, we identified six novel de novo truncating mutations in CHAMP1: c.1880C>G p.(Ser627*), c.1489C>T; p.(Arg497*), c.1876_1877delAG; p.(Ser626Leufs*4), c.1043G>A; p.(Trp348*), c.1002G>A; p.(Trp334*), and c.958_959delCC; p.(Pro320*). Our clinical observations confirm the phenotypic homogeneity of the syndrome, which represents therefore a distinct clinical entity. Besides, our functional studies show that CHAMP1 protein variants are delocalized from chromatin and are unable to bind to two of its direct partners, POGZ and HP1. These data suggest a pathogenic mechanism of the CHAMP1‐associated intellectual disability syndrome mediated by direct interacting partners of CHAMP1, several of which are involved in chromo/kinetochore‐related disorders.
Prenatal Diagnosis | 2008
Virginie Scotet; I. Duguépéroux; Marie-Pierre Audrézet; Martine Blayau; Pierre Boisseau; Hubert Journel; P. Parent; Claude Férec
This multicentric study presents 6 cases of Wolf-Hirschhorn syndrome (deletion of 4p) detected after a sonographic prenatal diagnosis of early intrauterine growth retardation with fetal abnormalities. Standard karyotyping on regular G-banding during pregnancy was normal in half of the cases. Fortunately, the associated sonographic signs of a typical face, cystic cerebral lesions, midline fusion defects and bilateral renal hypoplasia may help to refine specific indications for high-resolution banding and molecular analysis by in situ hybridization.